|
Market Data
Medtronic plc
Medtronic plc is a global medical technology leader focused on developing and commercializing device-based therapies for a variety of conditions. The company's core business revolves around four key segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. Medtronic's Cardiovascular portfolio offers solutions for cardiac rhythm management and structural heart disease, while its Neuroscience segment provides devices for spinal and brain therapies. The Medical Surgical segment focuses on surgical instruments and technologies, and the Diabetes segment offers insulin pumps and glucose monitoring systems. Founded in 1949, Medtronic operates internationally, providing innovative medical solutions to healthcare providers and patients worldwide.
MDT is currently trading at $87.10, giving Medtronic plc a market cap of 113.62B and a P/E ratio of 24.6. Today's range spans $87.10–$87.10, with shares opening at $87.10 and moving down $0.10 (0.1%) from the prior close. DailyIQ's technical score sits at 41/100 (HOLD) with a news sentiment reading of 52/100.
Over the past year MDT has traded between $79.93 and $106.33 - the current price is +9.0% off the 52-week low and -18.1% from the high. 36 analysts cover the stock with a Hold consensus and a mean 12-month target of $111.83 (range $100.00–$121.00), implying upside of +28.4%.
Sector rotation context matters for MDT's HOLD phase (41/100, HOLD): in Healthcare, large-cap names (113.62B market cap) with neutral technicals and neutral sentiment (52/100) are often in a staging area ahead of a rotation trade. The current P/E ratio stands at 24.6. Price: $87.10 (in the lower half of its 52-week range in $79.93–$106.33). When sector flows resume, names that consolidated cleanly rather than correcting sharply tend to lead the next leg - and MDT's current setup fits that pattern.
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $1.57 | - | - |
| Q3'26 | $1.69 | $1.36 | -19.5% |
| Q3'25 | $1.31 | $1.36 | +3.5% |
| Q2'25 | $1.23 | $1.26 | +2.5% |
| Q1'25 | $1.58 | $1.62 | +2.7% |
| Q4'24 | $1.36 | $1.39 | +2.2% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q4'26 | $9.6B | - | - |
| Q3'26 | $9.6B | $9.0B | -6.4% |
| Q3'25 | - | $9.0B | - |
| Q2'25 | - | $8.5B | - |
| Q1'25 | - | $8.9B | - |
| Q4'24 | - | $8.3B | - |
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).